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micrometastatic LN in 3 patients, and 4) weak FDG uptake in mediasti-
nal ipsilateral macrometastatic LN in 5 patients. 
Conclusions: Before therapeutic decision, an abnormal mediastinal 
FDG uptake must be conﬁrmed pathologically. In certain situations, 
SEM is also indicated when there is no abnormal uptake in the medias-
tinum. 
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Objective: Neuroendocrine (NE) lung tumors consist of typical carci-
noid (TC), atypical carcinoid (AC), large cell neuroendocrine carci-
noma (LCNEC) and small cell carcinoma (SCLC). The determinant of 
FDG uptake for NE lung tumors has not been well elucidated. The aim 
of the present study is to investigate the relationship of FDG uptake and 
glucose transporter type 1 (Glut-1) expression in NE lung tumors. 
Methods: NE lung tumor patients (n=32; age, mean ± s.d.=67.8±10y; 
male:female=28:4) who had underwent F-18 FDG-PET before treat-
ment were enrolled. There were 1 TC, 3 AC, 5 LCNEC, and 23 SCLC. 
FDG uptake was represented by maximum standardized uptake value 
(maxSUV). The parafﬁn sections of the tumor tissues were immunos-
tained for Glut-1 (Neomarker, 1:50). The relation of FDG uptake and 
Glut-1 expression was assessed by Pearson correlation analysis. 
Results: The maxSUVs of all NE lung tumors ranged from 0.6 to 29.5 
(mean±s.d.=7.7±5.4), whereas percentage Glut-1 expression ranged 
from 0 to 100% (18±24%). MaxSUVs of all NE lung tumors were 
signiﬁcantly correlated with percentage Glut-1 expression (r=0.6471, 
p=0.0001). In subgroup analyses, maxSUV was also signiﬁcantly cor-
related with Glut-1 expression in SCLC (n=23, r=0.6189, p=0.0016) 
and in non-small cell NE lung tumors (n=9, r=0.7039, p=0.0343). 
The maxSUV and the percentage Glut-1 expression were 1.7±2.0 and 
5.0±0.0%, 7.9±3.2 and 35.0±32.4%, and 7.6±3.7 and 12.6±14.1% 
for AC, LCNEC, and SCLC, respectively. MaxSUV of SCLC was 
signiﬁcantly higher than that of AC (p=0.007), but percentage Glut-1 
expression was not signiﬁcantly different among AC, LCNEC, and 
SCLC (p>0.05). One TC case had a maxSUV of 29.5 and 100% Glut-1 
expression.
Conclusions: In NE lung tumors, the maxSUV on FDG-PET was 
highly correlated with Glut-1 immunostaining positivity. This result 
suggests that Glut-1 expression is one of the determining factors of 
FDG uptake in NE lung tumors.
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Aims: To investigate whether the addition of FDG-PET to standard 
evaluation procedure alters tumour stage, mainly by detection of occult 
distant metastases, and thus has an impact on the ﬁnal treatment in 
patients planned for chemo-radiotherapy. 
Material and Methods: In June 2003 we added FDG-PET to conven-
tional evaluation of lung cancer in patients with NSCLC planned for 
high dose radiotherapy with concomitant chemotherapy. 
The routine evaluation consisted of clinical examination, chest x-ray, 
CT-scan of thorax and upper abdomen, bronchoscopy and comple-
mentary imaging as needed. The evaluation of the clinical data and 
the CT-scan was performed in a conference with the participation of 
at least one experienced pulmonary oncologist and an experienced 
chest radiologist. Based on the routine evaluation, totally 53 patients 
(32 men, 20 women) were in stage IIB-III and thus were planned for 
concomitant chemo-radiotherapy. These patients underwent FDG-PET 
as the ﬁnal part of the staging procedure.
Results: In a total of 53 patients, 10 patients (19%) were found to 
have distant metastases undiagnosed by routine evaluation. The initial 
management plan was altered in 8 cases (15%). 
Conclusion: Adding FDG-PET to routine clinical evaluation is justi-
ﬁed also in this clinical setting.
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Background: Papillary adenocarcinoma (PA) is a distinct histological 
subtype of adenocarcinoma of the lung, but its radiological ﬁndings 
have been rarely reported. Histologically, the micropapillary compo-
nent is well known characteristic feature of PA and has been found to 
be a distinct pathologic marker for poor prognosis. The purpose of this 
study is to evaluate characteristic Computed Tomographic (CT) ﬁnd-
ings of adenocarcinoma with micropapillary component (PA pattern). 
Methods: From January 2000 to February 2006, 1078 consecutive 
patients were conﬁrmed adenocarcinoma of the lung by histopathology, 
including 45 PA pattern (M:F=24:21, mean age, 59yrs). Chest CT was 
reviewed as consensus reading by two radiologists. The CT ﬁndings 
such as size, number, margin, character (consolidation or inﬁltration, 
cavity) of tumor, the presence of ground-glass opacity (GGO), spicula-
tion, lobulation, air-bronchogram, bubble lucency, and pleural tagging 
were assessed. 
Results: Dominant CT ﬁnding of PA pattern adenocarcinoma was soli-
tary mass or nodule (n=35, 78%). Another ﬁnding is central mass (n=9, 
20%) or inﬁltration (n=3, 7%). Spiculation (n=20, 44%) and lobulation 
(n=25, 56%) are common characteristics of nodules, however, GGO 
(n=9, 20%) and air-bronchogram or bubble lucency (n=12, 27%) is less 
